The myelodysplastic syndromes (MDS) are a group of malignancies with poor prognosis and obscure etiology. To better understand the distribution of MDS in the population and help generate etiologic hypotheses, we assessed potential clustering in the incidence of MDS in the state of Connecticut using
Incidence of myelodysplastic syndromes in a Swedish population
✍ Scribed by Anders Rådlund; Torben Thiede; Sören Hansen; Magnus Carlsson; Leif Engquist
- Book ID
- 114791896
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 398 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0902-4441
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Thrombocytopenia and platelet dysfunction contribute to hemorrhagic complications in the myelodysplastic syndromes (MDS). Reliable data regarding the frequency and consequences of thrombocytopenia in MDS are lacking. An extensive literature review indicated that the prevalence of thromb
## Abstract ## BACKGROUND. Myelodysplastic syndromes (MDS) became reportable to the Surveillance, Epidemiology, and End Results (SEER) Program (the United States cancer surveillance program) in 2001. This provided the first opportunity to examine the incidence and survival of patients with MDS in